Thermo Fisher Scientific TMO Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Consolidated revenues by Business | |||||
| Analytical Instruments | $7.55B+1.2% | $7.46B+2.8% | $7.26B+9.6% | $6.62B+9.1% | |
| Laboratory Products and Biopharma Services | $23.98B— | —— | $23.04B— | —— | |
| Life Sciences Solutions | $10.37B+7.7% | $9.63B-3.5% | $9.98B-26.3% | $13.53B-13.4% | |
| Specialty Diagnostics | $4.68B+3.6% | $4.51B+2.4% | $4.41B-7.5% | $4.76B-15.8% | |
| Consolidated revenues by Product | |||||
| Consumables | $18.66B+6.1% | $17.59B-0.1% | $17.6B-14.7% | $20.62B-8.8% | |
| Instruments | $7.3B-1.9% | $7.45B-2.6% | $7.65B-3.5% | $7.92B+2.2% | |
| Service revenues | $18.59B+4.2% | $17.85B+1.3% | $17.61B+7.6% | $16.37B+84.9% | |
| Consolidated revenues by Geography | |||||
| Asia-Pacific | $8.1B+1.8% | $7.96B+1.1% | $7.87B-3.0% | $8.12B+12.4% | |
| Europe | $11.83B+8.9% | $10.86B+1.1% | $10.74B-0.2% | $10.76B-3.3% | |
| North America | $23.03B+2.4% | $22.5B-1.1% | $22.76B-7.4% | $24.59B+25.1% | |
| Other regions | $1.6B+2.3% | $1.56B+5.5% | $1.48B+2.4% | $1.44B+20.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Thermo Fisher Scientific break its business down?
- Thermo Fisher Scientific (TMO) reports consolidated revenues by business across 4 parts — Analytical Instruments, Laboratory Products and Biopharma Services, Life Sciences Solutions and Specialty Diagnostics. Each is extracted from the segment footnotes and tracked over time.
- Where does Thermo Fisher Scientific's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Thermo Fisher Scientific's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
